Concentra (CON) Q1 FY26 earnings call: guidance and Q&A

What were the primary drivers behind the significant Q1 earnings beat, and did weather play a quantifiable positive role?

Matt DiCanio attributed the beat to higher-than-expected workers' compensation visit volumes and strong cost control and staffing efficiencies. Keith Newton confirmed that weather, specifically more ice and snow events compared to a mild prior year, was a net positive for the business by increasing slips and falls, particularly in the Northeast, though not quantified.

“what really drove the results in Q1 was the work comp visits and also our cost of services and cost control. So our teams did a great job from a staffing perspective. across the centers and the visit volume was higher than expected.”

asked by Ann Hynes · answered by Matthew DiCanio

Can you provide your perspective on current economic activity based on customer observations, and how these trends correlate with BLS and DOL data, given past decoupling?

Keith Newton noted a "no higher, no fire" environment earlier in the year but expressed optimism about recent net job gains. Matt DiCanio added that total employment, especially blue-collar, continues to grow, and Concentra is gaining market share. They acknowledged a disconnect with some broader economic data but are seeing stability and growth in their relevant segments.

“total employment continues to grow, especially blue collar, which is the patients that walk in our centers every day. There's less layoffs compared to prior year. So we're seeing stability, obviously, with our employer services visit volume is still below historical averages, but good news for us is total employment continues to grow. And clearly, we're gaining market share within the categories that we compete.”

asked by Justin Bowers · answered by Matthew DiCanio

Could you elaborate on the free cash flow guidance, particularly why the low end increased more than EBITDA, and the dynamics behind the strong conversion?

Matt DiCanio explained that the free cash flow guidance was raised primarily due to the higher EBITDA guidance. He clarified that while Q1 CapEx was lower, the full-year CapEx range of $70 million to $80 million remains unchanged, indicating that the FCF increase is predominantly driven by improved earnings.

“So we raised our free cash flow guidance, obviously, raised our EBITDA guide. So from a profit standpoint, we're moving higher. The CapEx was a little lower in Q1, but we still expect it to be between $70 million and $80 million for the full year. So really, we're just pushing up that guide there equivalent to what we saw from an EBITDA standpoint.”

asked by Benjamin Hendrix · answered by Matthew DiCanio

Why was the Q1 revenue per visit below typical rate increases, despite California's rate taking effect in March, and is the 3% full-year target still achievable?

Matt DiCanio clarified that overall revenue per visit was up 3.1%, with workers' comp up 2% and Employer Services up 2.7%, with visit mix influencing the overall figure. California's rate increase only impacted one month of Q1. He also noted that visit mix within workers' comp slightly lowered the reported 2%. Management expects to be on track for 3% or potentially higher for the full year.

“overall, revenue per visit was up 3.1%. You'll see in our investor deck, work comp was up 2% and Employer Services was up 2.7%. So there's some differences there because of visit mix. So that's why the overall revenue per visit is higher than the individual components with work comp as it's growing faster than Employer Services.”

asked by Mitchell Ostrovsky · answered by Matthew DiCanio

Are there any updates on New York workers' compensation rates, when is a final decision expected, and how quickly does Concentra plan to expand in New York once rates are known?

Keith Newton stated no new update but anticipates a decision this year, potentially effective January 1. He noted that while current rates are not ideal, they are an improvement. Concentra has analyzed the market and has a pipeline, allowing for selective and quick expansion when conditions are more attractive, while continuing de novo growth in other states in the interim.

“no new update. I'm not sure when we're going to hear something but anticipate it will happen this year. And that January 1, something will go into play. Right now, as we mentioned in the past, it's focused on the E&M codes, the evaluation and management codes that doctors use as far as coding level of service and that was not adjusted at all.”

asked by Unknown Analyst · answered by William Newton